Status:
COMPLETED
An Observational Study to Assess the Protocol for the COVID-19 Treatment in Burkina Faso
Lead Sponsor:
Centre Muraz
Conditions:
Coronavirus Infection
Eligibility:
All Genders
18-99 years
Brief Summary
This is an observational study to evaluate the effectiveness of the combinations Hydroxychloroquine + Azithromycin (HCQ-AZ) and Chloroquine + Azithromycin (CQ-AZ) in the treatment of Coronavirus (Covi...
Detailed Description
All patients who received one of the two combinations will be included in the study and followed-up until the patient is discharged from the hospital. They will be seen daily during the period of thei...
Eligibility Criteria
Inclusion
- Any patient over 18 years treated according to the standard of care
- Willing to participate in the study by giving an informed consent
Exclusion
- Patients under 18 years of age
- Not willing to participate in the study
Key Trial Info
Start Date :
April 24 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 30 2020
Estimated Enrollment :
153 Patients enrolled
Trial Details
Trial ID
NCT04445441
Start Date
April 24 2020
End Date
November 30 2020
Last Update
January 22 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Sourou Sanon University Hospital
Bobo-Dioulasso, Burkina Faso, 01
2
Tingadogo University Hospital
Ouagadougou, Burkina Faso, 15